AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+13.9%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.06B
AUM Growth
+$2.06B
Cap. Flow
+$28.8M
Cap. Flow %
1.4%
Top 10 Hldgs %
62.6%
Holding
111
New
10
Increased
20
Reduced
15
Closed
11

Top Buys

1
ALNY icon
Alnylam Pharmaceuticals
ALNY
$24.1M
2
MORF
Morphic Holding, Inc. Common Stock
MORF
$23.9M
3
MDCO
Medicines Co
MDCO
$20M
4
GBT
Global Blood Therapeutics, Inc.
GBT
$17M
5
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$17M

Top Sells

1
NVDA icon
NVIDIA
NVDA
$38.3M
2
AVTR icon
Avantor
AVTR
$14.7M
3
HTHT icon
Huazhu Hotels Group
HTHT
$12.7M
4
BPMC
Blueprint Medicines
BPMC
$11M
5
CHNG
Change Healthcare Inc. Common Stock
CHNG
$11M

Sector Composition

1 Healthcare 59.61%
2 Consumer Discretionary 31.67%
3 Technology 3.51%
4 Communication Services 1.1%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
26
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$15.6M 0.62% 200,000 +50,000 +33% +$3.9M
EPZM
27
DELISTED
Epizyme, Inc
EPZM
$15.5M 0.62% 1,500,000 -150,000 -9% -$1.55M
UBER icon
28
Uber
UBER
$196B
$15.2M 0.61% 500,000 – –
TPTX
29
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$15M 0.6% 400,000 +200,000 +100% +$7.52M
ASND icon
30
Ascendis Pharma
ASND
$11.8B
$14.4M 0.58% 150,000 – –
DRNA
31
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$14.4M 0.58% 1,000,000 – –
AGIO icon
32
Agios Pharmaceuticals
AGIO
$2.19B
$13M 0.52% 400,000 -100,000 -20% -$3.24M
IOVA icon
33
Iovance Biotherapeutics
IOVA
$807M
$12.7M 0.51% 700,000 – –
REAL icon
34
The RealReal
REAL
$879M
$12.6M 0.51% 565,000 +545,000 +2,725% +$12.2M
TCDA
35
DELISTED
Tricida, Inc. Common Stock
TCDA
$11.1M 0.45% 360,000 – –
STNE icon
36
StoneCo
STNE
$4.41B
$10.4M 0.42% 300,000 – –
YMAB icon
37
Y-mAbs Therapeutics
YMAB
$388M
$10.4M 0.42% 400,000 – –
XNCR icon
38
Xencor
XNCR
$580M
$10.1M 0.41% 300,000 +25,000 +9% +$843K
FIS icon
39
Fidelity National Information Services
FIS
$36.5B
$9.96M 0.4% +75,000 New +$9.96M
BOLD
40
DELISTED
Audentes Therapeutics, Inc
BOLD
$9.83M 0.39% 350,000 – –
AXDX
41
DELISTED
Accelerate Diagnostics
AXDX
$9.29M 0.37% 500,000 +50,000 +11% +$929K
BLUE
42
DELISTED
bluebird bio
BLUE
$9.18M 0.37% 100,000 – –
NKTR icon
43
Nektar Therapeutics
NKTR
$568M
$9.11M 0.37% 500,000 -200,000 -29% -$3.64M
ALBO
44
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$9M 0.36% 450,200 +200 +0% +$4K
MRUS icon
45
Merus
MRUS
$4.98B
$8.91M 0.36% 500,000 +150,000 +43% +$2.67M
HOOK
46
DELISTED
HOOKIPA Pharma
HOOK
$8.51M 0.34% 1,134,616 – –
REPL icon
47
Replimune Group
REPL
$422M
$8.34M 0.33% 600,000 – –
NERV icon
48
Minerva Neurosciences
NERV
$16.5M
$7.75M 0.31% +1,000,000 New +$7.75M
PRQR icon
49
ProQR Therapeutics
PRQR
$237M
$7.49M 0.3% 1,300,000 – –
TBIO
50
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$7.43M 0.3% 750,000 – –
1
2
3 4 5